Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Bought deal $5Million

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Apr 29, 2021 11:57am

133 Views

Post# 33091292

RE:RE:RE:Bought deal $5Million

Dilution, dilution, dilution and no clear purpose for the money which they previously and recently stated they wouldnt need. I'm hopeful they explain further and personally don't think it's an issue as this management team is much better than previous, but there is long history here on this topic.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market